Demographic data | Total No (%) | Osteosarcoma No (%) | Sarcoma Ewing No (%) | X2 | P-value |
---|---|---|---|---|---|
20 (54.1%):17(45.9%) | 5 (33.3%):10(66.7%) | 15 ((68.231.8%): %) 7 | 4.361 | 0.037 | |
11 (5 – 14) [2 – 18] | 13 (12 - 15)[3 – 18] | 5 (4 - 11 )[2 - 16] | -2.785* | 0.005 | |
Total No (%) | Osteosarcoma No (%) | Sarcoma Ewing No (%) | X2 | P-value | |
15 45.4% | 10 66.67% | 5 27.78% | 4.991 | 0.025 | |
16 48.5% | 11 73.33% | 5 27.78% | 6.798 | 0.009 | |
4 12.1% | 3 20.00% | 1 5.56% | 1.603 | 0.205 | |
5 15.2% | 1 6.67% | 4 22.22% | 1.540 | 0.215 | |
5 15.2% | 1 6.67% | 4 22.22% | 1.540 | 0.215 | |
2 6.1% | 0 0.00% | 2 11.11% | 1.774 | 0.183 | |
1 3.0% | 0 0.00% | 1 5.56% | 0.859 | 0.354 | |
7 21.3% | 2 13.33% | 5 27.78% | 1.021 | 0.312 | |
4 12.1% | 1 6.67% | 3 16.67 | 0.768 | 0.381 | |
5 15.2% | 1 6.67% | 4 22.22% | 1.540 | 0.215 | |
1 3.0% | 0 0.00% | 1 5.56% | 0.859 | 0.354 | |
3 9.1% | 3 20.00% | 0 0.00% | 3.960 | 0.047 | |
1 3.0% | 0 0.00% | 1 5.56% | 0.859 | 0.354 | |
Total No (%) | Osteosarcoma No (%) | Ewing Sarcoma No (%) | X2 | P-value | |
16 45.71% | 9 59.90% | 7 35% | 2.159 | 0.141 | |
5 14.28% | 1 6.60% | 4 20% | 1.244 | 0.265 | |
3 8.57% | 3 20% | 0 0% | 4.375 | 0.036 | |
2 5.71% | 1 6.60% | 1 5% | 0.044 | 0.834 | |
2 5.71% | 0 0% | 2 10% | 1.591 | 0.207 | |
2 5.71% | 1 6.60% | 1 5% | 0.044 | 0.834 | |
1 2.85% | 0 0% | 1 5% | 0.772 | 0.379 | |
1 2.85% | 0 0% | 1 5% | 0.772 | 0.379 | |
1 2.85% | 0 0% | 1 5% | 0.772 | 0.379 | |
1 2.85% | 0 0% | 1 5% | 0.772 | 0.379 | |
1 2.85% | 0 0% | 1 5% | 0.772 | 0.379 |
Variables | MSTS system | Independent t-test | |||
---|---|---|---|---|---|
Mean ± SD | Range | t | p-value | ||
73 ± 11 | 50 – 87 | ||||
0.533 | 0.603 | ||||
76 ± 10 | 65 – 87 | ||||
75 ± 7 | 62 – 82 | ||||
0.53 | 0.601 | ||||
73 ± 13 | 50 – 87 | ||||
76.29 ± 8.18 | 62 – 87 | ||||
3.106 | 0.008 | ||||
50.0 ± 0.0 | 50 – 50 | ||||
76.29 ± 8.18 | 62 – 87 | ||||
4.435 | <0.001 | ||||
57.5 ± 10.61 | 50 – 65 |